Guardant360 test detects DNA segments in the patient's blood, originated from the cancerous tumor or its metastasis
Representational Image
Israeli researchers have discovered a method for matching precise treatment to lung cancer patients through simple blood tests, Hebrew-language website "Ynet" reported on Monday.
The study, conducted by the oncology department at Soroka Hospital in southern Israel, examined the contribution of the use of "Guardant360" non-invasive liquid biopsy to match accurate treatment for patients with metastases.
ADVERTISEMENT
Guardant360 test detects DNA segments in the patient's blood, originated from the cancerous tumor or its metastasis.
After examining 116 advanced stage non-small-cell lung carcinoma cancer patients, the study concluded that 65 percent of the patients had a genetic modification that could be treated with drugs approved by the US Food and Drug Administration.
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
